Variation in post‐TAVR antiplatelet therapy utilization and associated outcomes: Insights from the STS/ACC TVT Registry
暂无分享,去创建一个
M. Mack | J. Rumsfeld | A. Kirtane | E. Peterson | D. Holmes | D. Cohen | V. Thourani | J. K. Harrison | S. Vemulapalli | A. Vora | M. Sherwood | David Dai | J. Harrison | D. Cohen
[1] J. Webb,et al. Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve: The ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) Randomized Clinical Trial. , 2017, JACC. Cardiovascular interventions.
[2] P. Stella,et al. Rationale and design of POPular-TAVI: antiPlatelet therapy fOr Patients undergoing Transcatheter Aortic Valve Implantation. , 2016, American heart journal.
[3] M. Farkouh,et al. Comparison of Dual-antiplatelet Therapy to Mono-antiplatelet Therapy After Transcatheter Aortic Valve Implantation: Systematic Review and Meta-analysis. , 2015, The Canadian journal of cardiology.
[4] John D. Carroll,et al. Clinical outcomes at 1 year following transcatheter aortic valve replacement. , 2015, JAMA.
[5] R. Pathak,et al. Dual versus single antiplatelet therapy in patients undergoing transcatheter aortic valve replacement: a systematic review and meta-analysis. , 2015, Heart, lung & circulation.
[6] Nancy M Albert,et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, The Journal of thoracic and cardiovascular surgery.
[7] B. Trimarco,et al. SAT-TAVI (single antiplatelet therapy for TAVI) study: a pilot randomized study comparing double to single antiplatelet therapy for transcatheter aortic valve implantation. , 2014, International journal of cardiology.
[8] Thoralf M Sundt,et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Journal of the American College of Cardiology.
[9] J. Mega,et al. Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events. , 2013, Journal of the American College of Cardiology.
[10] Danica Marinac-Dabic,et al. The STS-ACC transcatheter valve therapy national registry: a new partnership and infrastructure for the introduction and surveillance of medical devices and therapies. , 2013, Journal of the American College of Cardiology.
[11] O. Alfieri,et al. Guidelines on the management of valvular heart disease (version 2012). , 2012, European heart journal.
[12] O. Alfieri,et al. Guidelines on the management of valvular heart disease. , 2007, European heart journal.
[13] Sean M. O'Brien,et al. Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database. , 2012, Journal of the American College of Cardiology.
[14] D. Capodanno,et al. Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation. , 2011, The American journal of cardiology.
[15] Stuart J Pocock,et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. , 2011, The New England journal of medicine.
[16] S. Pocock,et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. , 2010, The New England journal of medicine.